Alzheimer’s disease(AD)is an age-related neurodegenerative disorder that poses a signifcant burden on socio-economic and healthcare systems worldwide.However,the currently available therapy of AD is limited,and new s...Alzheimer’s disease(AD)is an age-related neurodegenerative disorder that poses a signifcant burden on socio-economic and healthcare systems worldwide.However,the currently available therapy of AD is limited,and new strategies are needed to enhance the clearance ofβ-amyloid(Aβ)protein and improve cognitive function.Photobiomodulation(PBM)is a noninvasive and efective therapeutic method that has shown promise in treating various brain diseases.Here,we demonstrate that 1267-nm PBM signifcantly alleviates cognitive decline in the 5xFAD mouse model of AD and is safe as it does not induce a signifcant increase in cortical temperature.Moreover,with the combination of 3D tissue optical clearing imaging and automatic brain region segmentation,we show that PBM-mediated reductions of Aβplaques in diferent subregions of prefrontal cortex and the hippocampus are diferent.The PBM-induced lymphatic clearance of Aβfrom the brain is associated with improvement of memory and cognitive functions in 5xFAD mice.Our results suggest that the modulation of meningeal lymphatic vessels(MLVs)should play an important role in promoting Aβclearance.Collectively,this pilot study demonstrates that PBM can safely accelerate lymphatic clearance of Aβfrom the brain of 5xFAD mice,promoting improvement of neurocognitive status of AD animals suggesting that PBM can be an efective and bedside therapy for AD.展开更多
基金supported by the National Natural Science Foundation of China(NSFC)(Grant Nos.61860206009,81961138015,62375096,82372012,62375095,62105113 and 82001877)Key Research and Development Project of Hubei Province(No.2022BCA023)+1 种基金the Innovation Fund of WNLOSGO was supported by grant from the Russian Science Foundation 23-75-30001.
文摘Alzheimer’s disease(AD)is an age-related neurodegenerative disorder that poses a signifcant burden on socio-economic and healthcare systems worldwide.However,the currently available therapy of AD is limited,and new strategies are needed to enhance the clearance ofβ-amyloid(Aβ)protein and improve cognitive function.Photobiomodulation(PBM)is a noninvasive and efective therapeutic method that has shown promise in treating various brain diseases.Here,we demonstrate that 1267-nm PBM signifcantly alleviates cognitive decline in the 5xFAD mouse model of AD and is safe as it does not induce a signifcant increase in cortical temperature.Moreover,with the combination of 3D tissue optical clearing imaging and automatic brain region segmentation,we show that PBM-mediated reductions of Aβplaques in diferent subregions of prefrontal cortex and the hippocampus are diferent.The PBM-induced lymphatic clearance of Aβfrom the brain is associated with improvement of memory and cognitive functions in 5xFAD mice.Our results suggest that the modulation of meningeal lymphatic vessels(MLVs)should play an important role in promoting Aβclearance.Collectively,this pilot study demonstrates that PBM can safely accelerate lymphatic clearance of Aβfrom the brain of 5xFAD mice,promoting improvement of neurocognitive status of AD animals suggesting that PBM can be an efective and bedside therapy for AD.
